王婧, 宋永喜, 向波, 孔祥溢, 王永强, 王建波, 罗娜, 徐芹芹, 吕群燕. 2020年度国家自然科学基金临床肿瘤学科申请与资助项目分析和思考[J]. 中国肿瘤临床, 2021, 48(2): 79-84. DOI: 10.3969/j.issn.1000-8179.2021.02.115
引用本文: 王婧, 宋永喜, 向波, 孔祥溢, 王永强, 王建波, 罗娜, 徐芹芹, 吕群燕. 2020年度国家自然科学基金临床肿瘤学科申请与资助项目分析和思考[J]. 中国肿瘤临床, 2021, 48(2): 79-84. DOI: 10.3969/j.issn.1000-8179.2021.02.115
Jing Wang, Yongxi Song, Bo Xiang, Xiangyi Kong, Yongqiang Wang, Jianbo Wang, Na Luo, Qinqin Xu, Qunyan Lv. Analysis and reflection on the application and funding of clinical oncology programs of the National Natural Science Foundation of China in 2020[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(2): 79-84. DOI: 10.3969/j.issn.1000-8179.2021.02.115
Citation: Jing Wang, Yongxi Song, Bo Xiang, Xiangyi Kong, Yongqiang Wang, Jianbo Wang, Na Luo, Qinqin Xu, Qunyan Lv. Analysis and reflection on the application and funding of clinical oncology programs of the National Natural Science Foundation of China in 2020[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(2): 79-84. DOI: 10.3969/j.issn.1000-8179.2021.02.115

2020年度国家自然科学基金临床肿瘤学科申请与资助项目分析和思考

Analysis and reflection on the application and funding of clinical oncology programs of the National Natural Science Foundation of China in 2020

  • 摘要: 随着基于四类科学问题属性的分类评审的实施,国家自然科学基金委员会医学科学部临床肿瘤学科申请与资助项目也呈现出新的特点与趋势。本文总结了2020年度国家自然科学基金临床肿瘤学科面上项目、青年科学基金项目、地区科学基金项目的申请与资助概况,并按照四类科学问题属性、肿瘤靶器官类型、不同研究方向、2021年度启用的新学科代码体系,对2020年度临床肿瘤学科申请与资助的面上项目进行深入分析。同时,也结合肿瘤学研究发展的最新进展,探讨了2020年度临床肿瘤学科申请与资助项目的一些新特点。

     

    Abstract: The National Natural Science Foundation of China (NFSC) has implemented the application process according to four funding categories in line with the scientific nature of research and category-specific review. New features and trends of program application and funding have been observed in the field of clinical oncology under the Health Sciences Department of NFSC. This article summarizes the overview of program application and funding on clinical oncology by NSFC in the year of 2020, including General Programs, the Young Scientists Fund and the Fund for Less Developed Regions. Furthermore, the general programs applied and funded in 2020 were classified and analyzed in-depth according to the funding categories of the scientific nature, cancer types by site and research directions. We also investigated the programs in the context of the new application code system which will be used starting in 2021. In the meantime, some new characteristics were discussed regarding the program application and funding on clinical oncology in 2020 in combination with the progress of oncology research.

     

/

返回文章
返回